The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
“Long-COVID is Not New” Long-term Sequelae Common in Flu, Especially in Older Adults, Say Influenza Researchers
Vancouver, BC / April 5-8, 2022
Vancouver – Influenza started to make a comeback worldwide and in Canada towards the end of 2021, emerging from the 2020–2021 pandemic lockdowns. A symposium at the recent AMMI Canada-CACMID annual conference updated...
“Could Anything Be Worse than COVID?” A Flu Pandemic, Say Influenza Researchers
Online / December 8–9, 2021
Online – While acknowledging that the current focus is on SARS-CoV-2 vaccination, influenza researchers at this year’s Canadian Immunization Conference reminded delegates that, if scaled up to 2021, the 1918–1920 flu...
Influenza Researchers Explore Real-World Data for Flu-Vaccine Evaluation and Learnings for COVID-19
Online / December 1-3, 2020
Online – Although the COVID-19 pandemic dominates the infectious disease headlines, influenza remains a striking public-health problem in Canada, with up to 7 million people sickened during a non-pandemic flu season. The seasonal...
Evolution in Management of Pulmonary Arterial Hypertension (PAH)
Targeting of the Prostacyclin Pathway in PAH Editorial ReviewWritten by: Theodore Bosworth Steeve Provencher, MD, MPH, FRCPCDirector, Pulmonary Hypertension ProgramProfessor, Université LavalQuebec City, Quebec For the treatment...
Current and Future SLIT Tablet Insights
Barcelona, Spain / June 6-10, 2015
Barcelona - Sublingual immunotherapy (SLIT) is working its way into allergy clinics with two oral tablets approved for use in patients with allergic rhinitis to grass pollen in Canada1. This type of therapy has been available in Europe...
More Aggressive Strategies for Early Detection of Pulmonary Hypertension Supported by Outcome Trials
Barcelona, Spain / August 30-September 3, 2014
Barcelona - Pulmonary arterial hypertension (PAH) should be treated earlier and more aggressively, according to a new analysis of clinical trials with mortality and morbidity endpoints. By demonstrating that outcomes are better when...
Perspectives on Pulmonary Arterial Hypertension (PAH) - Reviews from published literature
The 6-Minute Walk Test: Rethinking Outcome Measures in PAH Editorial ReviewWritten by: Theodore Bosworth Paul Hernandez, MDCM, FRCPCRespirologist, QEII Health Sciences CentreProfessor, Department of MedicineDalhousie UniversityHalifax,...
Recent Trial Data Foster New Definitions of Optimal Management for Pulmonary Arterial Hypertension
Chicago, Illinois / October 26-31, 2013
Chicago - As a reflection of progress in the treatment of pulmonary arterial hypertension (PAH), experts speaking at the 2013 Chest meeting contend that they consider normalization of right ventricle function a viable therapeutic goal in at...
ABSTRACTS in PERSPECTIVE - Based on presentations from the Annual Congress of the European Respiratory Society (ERS)
Pulmonary Hypertension: New Therapies in Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
Barcelona, Spain / September 7-11, 2013
EDITORIAL OVERVIEW: John Granton, MDDirector, Pulmonary Hypertension ProgramToronto General HospitalUniversity of TorontoToronto, Ontario John Swiston, MDDirector, Pulmonary Hypertension ProgramVancouver General HospitalUniversity of...